Stock Earnings

Question 1

Enlivex Therapeutics Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Enlivex Therapeutics Ltd'in toplam varlıkları $27 olup, net loss $-15'dir.

Question 2

ENLV'ün temel finansal oranları nelerdir?

Accepted Answer

Enlivex Therapeutics Ltd'in cari oranı 6.75, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Enlivex Therapeutics Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Currently Enlivex Therapeutics Ltd data is not available.

Question 4

Enlivex Therapeutics Ltd kârlı mı?

Accepted Answer

no, son mali tablolara göre Enlivex Therapeutics Ltd'in net loss $-15'dir.

Question 5

Enlivex Therapeutics Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Enlivex Therapeutics Ltd'in yükümlülüğü 4'dir.

Question 6

Enlivex Therapeutics Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Enlivex Therapeutics Ltd'in toplam tedavüldeki hisse sayısı 23.65'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	4	4	6	7	6	3
Research & Development	10	10	18	17	12	5
Operating Expenses	15	15	25	25	19	9
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	-13	-15	-29	-31	-14	-11
Income Tax Expense	--	--	--	--	--	--
Net Income	-13	-15	-29	-31	-14	-11
Net Income Growth	-41%	-48%	-6%	121%	27%	22%
Shares Outstanding (Diluted)	23.85	20.51	18.57	18.39	17.86	13.17
Shares Change (YoY)	22%	10%	1%	3%	36%	52%
EPS (Diluted)	-0.54	-0.73	-1.56	-1.69	-0.81	-0.9
EPS Growth	-53%	-53%	-7%	109%	-10%	-19%
Free Cash Flow	-12	-13	-23	-32	-19	-12
Free Cash Flow Per Share	-0.5	-0.63	-1.23	-1.74	-1.06	-0.91
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-15	-15	-25	-25	-19	-9
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-15	-15	-25	-25	-19	-9
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Enlivex Therapeutics Ltd (ENLV) Price